Business Context and Reporting Period
This Form 6-K filing by GSK plc (GSK) reports a transaction in the company's own shares conducted on November 10, 2025. The filing covers the month of November 2025 and details a share repurchase executed through BNP Paribas SA as part of an existing buyback programme announced on September 30, 2025.
Key Financial Metrics
The filing focuses exclusively on capital structure and share repurchase activity. It does not contain revenue, profit, cash flow, or margin data.
- Shares Purchased (Nov 10, 2025): 170,000 ordinary shares.
- Price Range: Lowest 1,753.50p; Highest 1,779.00p.
- Volume-Weighted Average Price (VWAP): 1,768.72p.
- Programme Progress: Since September 30, 2025, GSK has purchased 8,329,000 ordinary shares.
- Treasury Shares Held: 255,793,844 ordinary shares.
- Shares in Issue (excluding Treasury): 4,059,634,530 ordinary shares.
- Total Voting Rights: 4,059,634,530.
- Treasury Voting Rights Percentage: 6.30%.
Material Changes
The primary material change is the reduction of shares in issue and the increase in treasury shares following the November 10 transaction. The total number of voting rights remains 4,059,634,530, which serves as the denominator for shareholder notification thresholds under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules. The percentage of voting rights attributable to treasury shares stands at 6.30%.
Guidance, Outlook, and Risks
The filing contains no new financial guidance, operational outlook, or management commentary regarding business performance. It includes a standard cautionary statement noting that forward-looking statements are subject to risks and uncertainties, referencing the "Risk Factors" section in GSK's 2024 Annual Report on Form 20-F and Q3 2025 Results.
Investor Verification Checklist
- Verify the total number of shares in issue (4,059,634,530) for calculating ownership percentages.
- Confirm the current percentage of voting rights held in treasury (6.30%) against regulatory thresholds.
- Review the cumulative buyback volume (8,329,000 shares) since the programme announcement on September 30, 2025.
- Check the specific trading venues (BATE, CHIX, XLON) and execution prices if analyzing market impact.